Citation: Xiangqian Cao, Chenkai Yang, Xiaodong Zhu, Mengxin Zhao, Yilin Yan, Zhengnan Huang, Jinming Cai, Jingming Zhuang, Shengzhou Li, Wei Li, Bing Shen. Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM[J]. Chinese Chemical Letters, ;2024, 35(8): 109199. doi: 10.1016/j.cclet.2023.109199 shu

Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM

Xiangqian Cao ^{a, 1} ,
Chenkai Yang ^{a, 1} ,
Xiaodong Zhu ^{b, 1} ,
Mengxin Zhao ^b ,
Yilin Yan ^a ,
Zhengnan Huang ^a ,
Jinming Cai ^a ,
Jingming Zhuang ^a ,
Shengzhou Li ^a ,
Wei Li ^{b, *,} ,
Bing Shen ^{a, *,}

a.
Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
b.
Department of Nanomedicine & Shanghai Key Lab of Cell Engineering, Naval Medical University, Shanghai 200433, China

liwei_dds@163.com

urodrshenbing@shsmu.edu.cn

Received Date: 2 July 2023
Revised Date: 10 October 2023
Accepted Date: 12 October 2023
Available Online: 13 October 2023

Figures(4)

Bladder cancer is a common malignant tumor of the urinary system with the potential to be treated by nano drug delivery system. The current work describes the synthesis and characterization of a novel nanomaterial to construct a nano-carrier based on 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatecholine (POPC) loaded doxorubicin (DOX) and embedded with gold nanoparticles and poly(N-isopropyl acrylamide) (PNIPAM) (GNPS@PNIPAM-POPC-DOX, GPPD). The dual-sensitive nanosystem gives simultaneous photothermal treatment and chemotherapy for bladder cancer. In vitro and in vivo properties were assessed using bladder cancer cell lines and mice and GPPD system distribution, tumor inhibition, and biocompatibility are reported. The system had favorable stability, low biological toxicity, controlled release efficiency, photothermal synergistic action, efficient photothermal transition, and favorable tumor suppressive effects. As a result, GPPD is a potential therapeutic approach for bladder cancer.
- Doxorubicin,
- Gold nanoparticles,
- Thermosensitive polymer,
- Photothermal therapy,
- Bladder cancer
1. [1]
  T. Tate, T. Xiang, S.E. Wobker, et al., Nat. Commun. 12 (2021) 6160. doi: 10.1038/s41467-021-26421-6
2. [2]
  R.L. Siegel, K.D. Miller, N.S. Wagle, et al., CA Cancer J. Clin. 73 (2023) 17–48. doi: 10.3322/caac.21763
3. [3]
  P. Jain, H. Kathuria, M. Momin, Pharmacol. Ther. 226 (2021) 107871. doi: 10.1016/j.pharmthera.2021.107871
4. [4]
  J. Gao, S. Ma, X. Zhao, et al., Chin. Chem. Lett. 32 (2021) 3954–3961. doi: 10.1016/j.cclet.2021.06.040
5. [5]
  Q. Xiao, X. Li, C. Liu, et al., Chin. Chem. Lett. 33 (2022) 4191–4196. doi: 10.1016/j.cclet.2022.01.083
6. [6]
  S.K. Huang, E. Mayhew, S. Gilani, et al., Cancer Res. 52 (1992) 6774–6781.
7. [7]
  N. Wang, Y. Zuo, S. Wu, et al., Acta Pharm. Sin. B 12 (2022) 4486–4500. doi: 10.1016/j.apsb.2022.05.032
8. [8]
  C. Huang, L. Zhang, Q. Guo, et al., Adv. Funct. Mater. 31 (2021) 2010637. doi: 10.1002/adfm.202010637
9. [9]
  Q. Li, Z. Shi, F. Zhang, et al., Acta Pharm. Sin. B 12 (2022) 107–134. doi: 10.1016/j.apsb.2021.05.031
10. [10]
  C. Lin, H. Hao, L. Mei, et al., Smart Mater. Med. 1 (2020) 150–167. doi: 10.1016/j.smaim.2020.09.001
11. [11]
  X. Li, J.F. Lovell, J. Yoon, et al., Nat. Rev. Clin. Oncol. 17 (2020) 657–674. doi: 10.1038/s41571-020-0410-2
12. [12]
  M.H. Jazayeri, T. Aghaie, R. Nedaeinia, et al., Cancer Immunol. Immunother. 69 (2020) 1833–1840. doi: 10.1007/s00262-020-02559-y
13. [13]
  S.K. Cho, K. Emoto, L.J. Su, et al., J. Biomed. Nanotechnol. 10 (2014) 1267–1276. doi: 10.1166/jbn.2014.1838
14. [14]
  T. Chen, W. Zeng, C. Tie, et al., Bioact. Mater. 10 (2022) 515–525.
15. [15]
  T.Y. Lin, Y. Li, Q. Liu, et al., Biomaterials 104 (2016) 339–351. doi: 10.1016/j.biomaterials.2016.07.026
16. [16]
  L.R. Hirsch, R.J. Stafford, J.A. Bankson, et al., Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13549–13554. doi: 10.1073/pnas.2232479100
17. [17]
  D.P. O'Neal, L.R. Hirsch, N.J. Halas, et al., Cancer Lett. 209 (2004) 171–176. doi: 10.1016/j.canlet.2004.02.004
18. [18]
  H.M. Smilowitz, L.J. Tarmu, M.M. Sanders, et al., Int. J. Nanomedicine 12 (2017) 7937–7946. doi: 10.2147/IJN.S140977
19. [19]
  J.K. Cheong, V. Popov, E. Alchera, et al., Comput. Biol. Med. 138 (2021) 104881. doi: 10.1016/j.compbiomed.2021.104881
20. [20]
  Y. Kwon, Y. Choi, J. Jang, et al., Pharmaceutics 12 (2020) 204. doi: 10.3390/pharmaceutics12030204
21. [21]
  R. Yadav, S. Kumar, P. Narang, et al., J. Colloid Interface Sci. 582 (2021) 478–487. doi: 10.1016/j.jcis.2020.08.074
22. [22]
  H. Wang, X. Yang, C. Hu, et al., Chin. Chem. Lett. 33 (2022) 4179–4184. doi: 10.1016/j.cclet.2022.02.022
23. [23]
  Z. Shi, Q. Li, L. Mei, Chin. Chem. Lett. 31 (2020) 1345–1356. doi: 10.1016/j.cclet.2020.03.001
24. [24]
  Z. Li, Y. Yang, H. Wei, et al., J. Control. Release 338 (2021) 719–730. doi: 10.1016/j.jconrel.2021.09.005
25. [25]
  W. Li, M. Nakayama, J. Akimoto, et al., Polymer 52 (2011) 3783–3790. doi: 10.1016/j.polymer.2011.06.026
26. [26]
  D. Petroni, C. Riccardi, D. Cavasso, et al., Molecules 26 (2021) 6591. doi: 10.3390/molecules26216591
27. [27]
  X. Zhu, Y. Sun, D. Chen, et al., J. Control. Release 254 (2017) 107–118. doi: 10.1016/j.jconrel.2017.03.038
28. [28]
  H. Zhang, J. Lu, Y. Zhang, et al., Chin. Chem. Lett. 34 (2023) 107450. doi: 10.1016/j.cclet.2022.04.048
29. [29]
  F. Zhang, Y. Hou, M. Zhu, et al., Adv. Sci. 8 (2021) e2102666. doi: 10.1002/advs.202102666
30. [30]
  F. Zhang, D. Chen, Y. Wang, et al., Nanomedicine 12 (2017) 1575–1589. doi: 10.2217/nnm-2017-0126
31. [31]
  F. Zhang, X. Zhu, J. Gong, et al., Nanomedicine 11 (2016) 1993–2006. doi: 10.2217/nnm-2016-0139
32. [32]
  M. Yu, J. Yu, Y. Yi, et al., J. Control. Release 347 (2022) 104–114. doi: 10.1016/j.jconrel.2022.04.047
33. [33]
  W. Li, J. Li, J. Gao, et al., Biomaterials 32 (2011) 3832–3844. doi: 10.1016/j.biomaterials.2011.01.075
1. [1]
  Xuejian Xing , Pan Zhu , E Pang , Shaojing Zhao , Yu Tang , Zheyu Hu , Quchang Ouyang , Minhuan Lan . D-A-D-structured boron-dipyrromethene with aggregation-induced enhanced phototherapeutic efficiency for near-infrared fluorescent and photoacoustic imaging-guided synergistic photodynamic and photothermal cancer therapy. Chinese Chemical Letters, 2024, 35(10): 109452-. doi: 10.1016/j.cclet.2023.109452
2. [2]
  Xiao-Fang Lv , Xiao-Yun Ran , Yu Zhao , Rui-Rui Zhang , Li-Na Zhang , Jing Shi , Ji-Xuan Xu , Qing-Quan Kong , Xiao-Qi Yu , Kun Li . Combing NIR-Ⅱ molecular dye with magnetic nanoparticles for enhanced photothermal theranostics with a 95.6% photothermal conversion efficiency. Chinese Chemical Letters, 2025, 36(4): 110027-. doi: 10.1016/j.cclet.2024.110027
3. [3]
  Tingting Hu , Chao Shen , Xueyan Wang , Fengbo Wu , Zhiyao He . Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy. Chinese Chemical Letters, 2024, 35(11): 109562-. doi: 10.1016/j.cclet.2024.109562
4. [4]
  Jiangshan Xu , Weifei Zhang , Zhengwen Cai , Yong Li , Long Bai , Shaojingya Gao , Qiang Sun , Yunfeng Lin . Tetrahedron DNA nanostructure/iron-based nanomaterials for combined tumor therapy. Chinese Chemical Letters, 2024, 35(11): 109620-. doi: 10.1016/j.cclet.2024.109620
5. [5]
  Shuheng Zhang , Yuanyuan Zhang , Wanyu Wang , Yuzhu Hu , Xinchuan Chen , Bilan Wang , Xiang Gao . A combination strategy of DOX and VEGFR-2 targeted inhibitor based on nanomicelle for enhancing lymphoma therapy. Chinese Chemical Letters, 2024, 35(12): 109658-. doi: 10.1016/j.cclet.2024.109658
6. [6]
  Hongyi Huang , Siyao Che , Wenjie Zhou , Yunchu Zhang , Weiling Zhuo , Xijing Yang , Songping Zheng , Jiagang Liu , Xiang Gao . Apatinib potentiates doxorubicin with cRGD-functionalized pH-sensitive micelles against glioma. Chinese Chemical Letters, 2025, 36(5): 110084-. doi: 10.1016/j.cclet.2024.110084
7. [7]
  Yu Qin , Mingyang Huang , Chenlu Huang , Hannah L. Perry , Linhua Zhang , Dunwan Zhu . O₂-generating multifunctional polymeric micelles for highly efficient and selective photodynamic-photothermal therapy in melanoma. Chinese Chemical Letters, 2024, 35(7): 109171-. doi: 10.1016/j.cclet.2023.109171
8. [8]
  Leichen Wang , Anqing Mei , Na Li , Xiaohong Ruan , Xu Sun , Yu Cai , Jinjun Shao , Xiaochen Dong . Aza-BODIPY dye with unexpected bromination and high singlet oxygen quantum yield for photoacoustic imaging-guided synergetic photodynamic/photothermal therapy. Chinese Chemical Letters, 2024, 35(6): 108974-. doi: 10.1016/j.cclet.2023.108974
9. [9]
  Yongkang Yue , Zhou Xu , Kaiqing Ma , Fangjun Huo , Xuemei Qin , Kuanshou Zhang , Caixia Yin . HSA shrinkage optimizes the photostability of embedded dyes fundamentally to amplify their efficiency as photothermal materials. Chinese Chemical Letters, 2024, 35(8): 109223-. doi: 10.1016/j.cclet.2023.109223
10. [10]
  Yiqiao Chen , Ao Liu , Biwen Yang , Zhenzhen Li , Binggang Ye , Zhouyi Guo , Zhiming Liu , Haolin Chen . Photoluminescence and photothermal conversion in boric acid derived carbon dots for targeted microbial theranostics. Chinese Chemical Letters, 2024, 35(9): 109295-. doi: 10.1016/j.cclet.2023.109295
11. [11]
  Songtao Cai , Liuying Wu , Yuan Li , Soham Samanta , Jinying Wang , Bing Liu , Feihu Wu , Kaitao Lai , Yingchao Liu , Junle Qu , Zhigang Yang . Intermolecular hydrogen-bonding as a robust tool toward significantly improving the photothermal conversion efficiency of a NIR-II squaraine dye. Chinese Chemical Letters, 2024, 35(4): 108599-. doi: 10.1016/j.cclet.2023.108599
12. [12]
  Yiyang Shen , Zhen Zhang , Ruyi Liang , Tongbo Wu . Unraveling the interplay of DNAzyme and interfacial factors for enhanced biosensing. Chinese Chemical Letters, 2024, 35(12): 109638-. doi: 10.1016/j.cclet.2024.109638
13. [13]
  Yupeng Liu , Hui Wang , Songnan Qu . Review on near-infrared absorbing/emissive carbon dots: From preparation to multi-functional application. Chinese Chemical Letters, 2025, 36(5): 110618-. doi: 10.1016/j.cclet.2024.110618
14. [14]
  Tianze Wang , Junyi Ren , Dongxiang Zhang , Huan Wang , Jianjun Du , Xin-Dong Jiang , Guiling Wang . Development of functional dye with redshifted absorption based on Knoevenagel condensation at 1-site in phenyl[b]-fused BODIPY. Chinese Chemical Letters, 2024, 35(6): 108862-. doi: 10.1016/j.cclet.2023.108862
15. [15]
  Di An , Mingdong She , Ziyang Zhang , Ting Zhang , Miaomiao Xu , Jinjun Shao , Qian Shen , Xuna Tang . Light-responsive nanomaterials for biofilm removal in root canal treatment. Chinese Chemical Letters, 2025, 36(2): 109841-. doi: 10.1016/j.cclet.2024.109841
16. [16]
  Qianyun Ye , Yuanyuan Liang , Yuhe Yuan , Xiaohuan Sun , Liqi Zhu , Xuan Wu , Jie Han , Rong Guo . pH-responsive chiral supramolecular cysteine-Zn²⁺-indocyanine green assemblies for triple-level chirality-specific anti-tumor efficacy. Chinese Chemical Letters, 2025, 36(5): 110432-. doi: 10.1016/j.cclet.2024.110432
17. [17]
  Ying Zhang , Chuang Shen , Jiaxu Zhang , Qi Shen , Fei Xu , Shengheng Wang , Jiuyi Hu , Faisal Saleem , Feng Huang , Zhimin Luo . Ultrasmall PtCu nanosheets as a broadband phototheranostic agent in near-infrared biowindow. Chinese Chemical Letters, 2025, 36(6): 111059-. doi: 10.1016/j.cclet.2025.111059
18. [18]
  Lulu Cao , Yikun Li , Dongxiang Zhang , Shuai Yue , Rong Shang , Xin-Dong Jiang , Jianjun Du . Engineering aggregates of julolidine-substituted aza-BODIPY nanoparticles for NIR-II photothermal therapy. Chinese Chemical Letters, 2024, 35(12): 109735-. doi: 10.1016/j.cclet.2024.109735
19. [19]
  Ze Wang , Hao Liang , Annan Liu , Xingchen Li , Lin Guan , Lei Li , Liang He , Andrew K. Whittaker , Bai Yang , Quan Lin . Strength through unity: Alkaline phosphatase-responsive AIEgen nanoprobe for aggregation-enhanced multi-mode imaging and photothermal therapy of metastatic prostate cancer. Chinese Chemical Letters, 2025, 36(2): 109765-. doi: 10.1016/j.cclet.2024.109765
20. [20]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656

Get Citation

PDF

XML

Metrics

PDF Downloads(3)
Abstract views(990)
HTML views(26)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142